Bex Pharma SRL
Bex Pharma reported total assets of €1.14m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026).
The score of Bex Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bex Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Mar 2026
- Year ended 31 Dec 2024filed on 02 Apr 2025
- Year ended 31 Dec 2023filed on 29 Apr 2024
- Year ended 31 Dec 2022filed on 07 Apr 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
Bex Pharma's financial analysis
- Solvency28.1%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bex Pharma
Bex Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.988.489
- VAT number
- BE0681988489
- Peppol
- Registered · 0208:0681988489 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2017
- Registered office
- 9255 Buggenhout
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Activities of holding companies (NACE 64210)
Bex Pharma (SRL) has been based in Buggenhout since 2017, active in: activities of holding companies. For 2025, it reports a net profit of 30,226 € and equity of 319,718 €; its revenue is not published. Its solvency stands at 28.1%, below the median of its sector (55.6%).
Companies similar to Bex Pharma
Companies in the same business, of comparable size and area, outside its group.
- Bas Agri Holding Activities of holding companies Assenede · balance sheet €1.14m
- D.H. Activities of holding companies Raeren · balance sheet €1.13m
- Furkan Management Activities of holding companies Brasschaat · balance sheet €1.13m
- Be-Hold Activities of holding companies Maaseik · balance sheet €1.14m
- Kris Boonen Management Activities of holding companies Hamont-Achel · balance sheet €1.13m
- Linitech Activities of holding companies Sint-Niklaas · balance sheet €1.14m
- Goldspring Activities of holding companies Rebecq · balance sheet €1.14m
- Apollo 18 Activities of holding companies Tessenderlo-Ham · balance sheet €1.15m
Frequently asked questions about Bex Pharma
What is the revenue of Bex Pharma?
Bex Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bex Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0681988489 for Bex Pharma, if the company is VAT-registered. Its company number (CBE) is 0681.988.489.
Where is the registered office of Bex Pharma?
According to the CBE register, the registered office of Bex Pharma is in 9255 Buggenhout.
What is the equity of Bex Pharma?
At the close of the 2025 financial year, the equity of Bex Pharma amounts to 319,718 €, a solvency of 28.1% of total assets.
Who manages Bex Pharma?
The register lists 1 active mandates at Bex Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bex Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →